Genetic marker test for lupus
CA 2365875 A1 · Owner: Cantor, Rita M. · Inventors: Tsao, Betty P.; Cantor, Rita M.; Rotter, Jerome I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed is a genetic testing method for diagnosing systemic lupus erythematosus (SLE) in a human subject. The method is related to amplifying nucleic acids from human tissue samples and analyzing for a variant allele of a gene encoding poly(ADP-ribosyl)transferase expression (PARP) which is , diagnostic of SLE or indicates a genetic predisposition for developing SLE. Also disclosed are useful oligonuclotide primers primer sets and genetic , testing kits for detecting a genetic predisposition for developing SLE.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.